Home » Trunome Shark Tank India Season 2

Trunome Shark Tank India Season 2

by IndiaSuccessStories
0 comment
Trunome Shark Tank India Season 2 Got 1.5 crores Funding in Exchange of 2% Equity by Anupam Mittal, Vineeta Singh, Aman Gupta and Peyush Bansal.

Trunome Shark Tank India Season 2

Pitch no 131 with company details


The goal of Acrannolife Genomics is to create technologies that will allow us to offer point-of-care pharmacogenomics and genomic diagnostics testing at the lowest possible cost. Its main goal is to meet the demands of the healthcare sector by using genetic testing and personalized medications, revolutionizing healthcare in India via the use of cutting-edge technologies in a sustainable and cost-effective manner.

Founder of Trunome

Trunome’s founders Avinash Ramani and Agragesh Ramani.

Trunome Funding Round

Company Name


Shark Tank India Season


Episode No


Season No





Diagnosis and monitoring platform for chronic diseases

Original Ask

1.5 crores for 1% Equity


1.5 crores for 2% Equity

Invested By:

Anupam Mittal, Vineeta Singh, Aman Gupta and Peyush Bansal

Trunome's platform offered a comprehensive suite of tools for diagnosing and monitoring chronic diseases, empowering patients to take control of their health outcomes. By combining advanced medical algorithms, wearable sensors, and user-friendly interfaces, their solution enabled individuals to track vital health metrics, receive personalized recommendations, and communicate with healthcare professionals remotely.

The Pitch:

Trunome entered the Shark Tank with a groundbreaking idea: a diagnosis and monitoring platform for chronic diseases. Their platform aimed to revolutionize healthcare by providing patients with convenient and accurate tools to manage their conditions effectively. Seeking an investment of 1.5 crores for a 1% equity stake, Trunome showcased their innovative approach to leveraging technology in healthcare.

The Deal:

Trunome's pitch resonated with the sharks, and they secured a deal of 1.5 crores for a 2% equity stake. The sharks recognized the potential of Trunome's platform to disrupt the healthcare industry and improve patient outcomes. By investing in Trunome, they not only supported innovation in healthcare but also gained exposure to a promising market with significant growth opportunities.

Investors Behind Trunome

Anupam Mittal, Vineeta Singh, Aman Gupta and Peyush Bansal: With the investment secured, Trunome could accelerate the development and deployment of their platform, expanding their reach to a wider audience of patients and healthcare providers. They could invest in research and development to enhance the functionality and effectiveness of their tools, ensuring they remain at the forefront of healthcare innovation.


Trunome's success on Shark Tank validated the demand for innovative healthcare solutions and highlighted the importance of leveraging technology to address pressing medical challenges. By harnessing the power of data, connectivity, and artificial intelligence, Trunome aimed to empower individuals to lead healthier lives and transform the way chronic diseases are managed and treated.

You may also like

Leave a Comment

Indian Success Stories Logo

Indian Success Stories is committed to inspiring the world’s visionary leaders who are driven to make a difference with their ground-breaking concepts, ventures, and viewpoints. Join together with us to match your business with a community that is unstoppable and working to improve everyone’s future.

Edtior's Picks

Latest Articles

Copyright © 2024 Indian Success Stories. All rights reserved.